Literature DB >> 12628766

Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum.

P R Boag1, J C Parsons, P J A Presidente, T W Spithill, J L Sexton.   

Abstract

Infection with Ancylostoma caninum, an intestinal hookworm of dogs, can cause debilitating and potentially life-threatening disease. In the current study, protective immunity to hookworm infection was induced in dogs following vaccination with irradiation-attenuated third-stage larvae (L3) with significant reductions in both worm (P<0.03) and faecal egg counts (P<0.0004) following a challenge infection. Vaccination with irradiated L3 and challenge with infective L3 stimulated a dominant antibody response to antigens of less than 20 kDa in an excretory/secretory extract from adult parasites. Immunoscreening of an adult A. caninum cDNA library with antisera from the vaccine trial identified a number of clones. The three clones with the strongest immunoreactivity proved to be identical and encoded a peptide with similarity to the N-terminal domain of the tissue matrix metalloproteinase inhibitor (TIMP)-2 mammalian tissue metalloproteinase inhibitor family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628766     DOI: 10.1016/s0165-2427(03)00006-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum.

Authors:  Bin Zhan; Sen Liu; Samirah Perally; Jian Xue; Ricardo Fujiwara; Peter Brophy; Shuhua Xiao; Yueyuan Liu; Jianjun Feng; Angela Williamson; Yan Wang; Lilian L Bueno; Susana Mendez; Gaddam Goud; Jeffrey M Bethony; John M Hawdon; Alex Loukas; Karen Jones; Peter J Hotez
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Evaluation of parasitological and immunological aspects of acute infection by Ancylostoma caninum and Ancylostoma braziliense in mixed-breed dogs.

Authors:  Sílvia Regina Costa Dias; Denílson Eduardo Silva Cunha; Sydnei Magno da Silva; Hudson Andrade Dos Santos; Ricardo Toshio Fujiwara; Elida Mara Leite Rabelo
Journal:  Parasitol Res       Date:  2013-03-14       Impact factor: 2.289

3.  A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.

Authors:  Erin E Thacker; Masaharu Nakayama; Bruce F Smith; R Curtis Bird; Zhanat Muminova; Theresa V Strong; Laura Timares; Nikolay Korokhov; Ann Marie O'Neill; Tanja D de Gruijl; Joel N Glasgow; Kenzaburo Tani; David T Curiel
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

Review 4.  The role of nuclear technologies in the diagnosis and control of livestock diseases--a review.

Authors:  Gerrit J Viljoen; Antony G Luckins
Journal:  Trop Anim Health Prod       Date:  2012-10       Impact factor: 1.559

5.  Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs.

Authors:  Alex Loukas; Jeffrey M Bethony; Susana Mendez; Ricardo T Fujiwara; Gaddam Narsa Goud; Najju Ranjit; Bin Zhan; Karen Jones; Maria Elena Bottazzi; Peter J Hotez
Journal:  PLoS Med       Date:  2005-10-04       Impact factor: 11.069

Review 6.  Promising Technologies in the Field of Helminth Vaccines.

Authors:  Dilhan J Perera; Momar Ndao
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 7.561

7.  Developing Immune Profiles of Endangered Australian Sea Lion (Neophoca cinerea) Pups Within the Context of Endemic Hookworm (Uncinaria sanguinis) Infection.

Authors:  María-Ignacia Meza Cerda; Rachael Gray; Peter C Thomson; Loreena Butcher; Kelly Simpson; Abby Cameron; Alan D Marcus; Damien P Higgins
Journal:  Front Vet Sci       Date:  2022-04-21

Review 8.  Of dogs and hookworms: man's best friend and his parasites as a model for translational biomedical research.

Authors:  Catherine Shepherd; Phurpa Wangchuk; Alex Loukas
Journal:  Parasit Vectors       Date:  2018-01-25       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.